Bioventus Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Rob Claypoole
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 2.8yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Healing Numbers, Hurting Valuation: Bioventus' Mixed Bag In Q2 2024
Aug 12Bioventus: Bullish On Path To Profitability
Jan 24Bioventus: Reiterating Buy Thesis Following Q2 Earnings
Sep 08Bioventus Non-GAAP EPS of $0.10 misses by $0.06, revenue of $140.3M beats by $1.97M
Aug 11Bioventus stock rises as FDA clears SonaStar Elite for use in tumor removal
Aug 03Bioventus: Strong Value Gap, Insulated Via Leading Market Share
Jun 14Bioventus: Thoughts After An Active First Year
Mar 29CEO
Rob Claypoole (52 yo)
less than a year
Tenure
Mr. Robert E. Claypoole, also known as Rob, is President, Chief Executive Officer and Director of Bioventus Inc. from January 10, 2024. He was Executive Vice President and President, US for Mlnlycke Health...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Senior VP & CFO | 2.8yrs | US$1.06m | 0.13% $ 905.8k | |
| Senior VP | 7.3yrs | US$924.52k | 0.15% $ 1.0m | |
| President | less than a year | no data | no data | |
| Senior Vice President of Operations | 1.2yrs | no data | no data | |
| Vice President of Investor Relations & Treasurer | no data | no data | no data | |
| Senior VP & Chief Compliance Officer | 4.3yrs | no data | 0.063% $ 439.6k | |
| Senior VP & Chief Human Resources Officer | 1.7yrs | no data | no data | |
| Managing Director of China & Asia Pacific | 3.8yrs | no data | no data |
2.8yrs
Average Tenure
58.5yo
Average Age
Experienced Management: BVS's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | no data | no data | |
| Independent Director | 4.3yrs | US$153.23k | 0.15% $ 1.1m | |
| Independent Director | 1.9yrs | US$211.70k | 0.070% $ 486.1k | |
| Independent Director | 4.3yrs | US$150.73k | 0.090% $ 626.8k | |
| Independent Chairman of the Board | 4.3yrs | US$199.48k | 0.35% $ 2.5m | |
| Independent Director | 4.3yrs | US$148.23k | 0.090% $ 626.8k | |
| Independent Director | 4.3yrs | US$165.73k | 0.12% $ 847.9k | |
| Independent Director | 3.4yrs | US$158.23k | 0.080% $ 560.1k | |
| Independent Director | 4.3yrs | no data | 0.018% $ 124.8k | |
| Independent Director | 3.2yrs | US$150.73k | 0.076% $ 532.9k | |
| Independent Director | 2.9yrs | US$156.98k | 0.074% $ 514.3k |
4.3yrs
Average Tenure
58yo
Average Age
Experienced Board: BVS's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 10:04 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/28 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bioventus Inc. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| William Plovanic | Canaccord Genuity |
| Caitlin Cronin | Canaccord Genuity |
| Kyle Rose | Canaccord Genuity |